Benzimidazoles: An Ideal Privileged Drug Scaffold for the Design of Multitargeted Anti-inflammatory Ligands

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|14|9|747-767

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.14, Iss.9, 2014-07, pp. : 747-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1,2,4-Oxadiazole as a Privileged Scaffold for Anti-inflammatory and Analgesic Activities: A Review

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 18, 2018-11 ,pp. : 1536-1547

Bentham Science Publishers

Access to resources Recommend Favorite

Insight into Drug Design and Development of Anti-inflammatory Agents

By  

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 67-78

Bentham Science Publishers

Access to resources Recommend Favorite

Rhodanine as a Privileged Scaffold in Drug Discovery

By  

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1596-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Evaluation of Transdermal Drug Delivery System for Curcumin as an Anti-Inflammatory Drug

By Patel Nikunjana   Patel Natvar   Patel Rakesh  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 2, 2009-02 ,pp. : 234-242

Informa Healthcare

Access to resources Recommend Favorite

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1488-1508

Bentham Science Publishers

Access to resources Recommend Favorite